CMV Cytotoxic T-Lymphocytes therapy(New York Medical College)

N/A

Report date: 2024/07/03 21:31:43

Base Information

Drug NameCMV Cytotoxic T-Lymphocytes therapy(New York Medical College)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Virus-specific T Cell therapyCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Cytotoxic T-lymphocytes therapy

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsCytomegalovirus Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesNew York Medical College

China Registration ClassN/A

Develop Information

Active CompaniesNew York Medical College

Inactive CompaniesN/A

Active IndicationsCytomegalovirus Infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A